List of Tables
Table 1. Global Peptide-Based Vaccines for Cancer Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Peptide-Based Vaccines for Cancer Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Peptide-Based Vaccines for Cancer Market Competitive Situation by Manufacturers in 2024
Table 4. Global Peptide-Based Vaccines for Cancer Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Peptide-Based Vaccines for Cancer Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Peptide-Based Vaccines for Cancer Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Peptide-Based Vaccines for Cancer Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Peptide-Based Vaccines for Cancer Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Peptide-Based Vaccines for Cancer, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Peptide-Based Vaccines for Cancer, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peptide-Based Vaccines for Cancer, Product Type & Application
Table 12. Global Key Manufacturers of Peptide-Based Vaccines for Cancer, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peptide-Based Vaccines for Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-Based Vaccines for Cancer as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peptide-Based Vaccines for Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Peptide-Based Vaccines for Cancer Sales by Region (2020-2025) & (K Units)
Table 18. Global Peptide-Based Vaccines for Cancer Sales Market Share by Region (2020-2025)
Table 19. Global Peptide-Based Vaccines for Cancer Sales by Region (2026-2031) & (K Units)
Table 20. Global Peptide-Based Vaccines for Cancer Sales Market Share by Region (2026-2031)
Table 21. Global Peptide-Based Vaccines for Cancer Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Peptide-Based Vaccines for Cancer Revenue Market Share by Region (2020-2025)
Table 23. Global Peptide-Based Vaccines for Cancer Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Peptide-Based Vaccines for Cancer Revenue Market Share by Region (2026-2031)
Table 25. North America Peptide-Based Vaccines for Cancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Peptide-Based Vaccines for Cancer Sales by Country (2020-2025) & (K Units)
Table 27. North America Peptide-Based Vaccines for Cancer Sales by Country (2026-2031) & (K Units)
Table 28. North America Peptide-Based Vaccines for Cancer Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Peptide-Based Vaccines for Cancer Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Peptide-Based Vaccines for Cancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Peptide-Based Vaccines for Cancer Sales by Country (2020-2025) & (K Units)
Table 32. Europe Peptide-Based Vaccines for Cancer Sales by Country (2026-2031) & (K Units)
Table 33. Europe Peptide-Based Vaccines for Cancer Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Peptide-Based Vaccines for Cancer Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Peptide-Based Vaccines for Cancer Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Peptide-Based Vaccines for Cancer Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Peptide-Based Vaccines for Cancer Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Peptide-Based Vaccines for Cancer Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Peptide-Based Vaccines for Cancer Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peptide-Based Vaccines for Cancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Peptide-Based Vaccines for Cancer Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Peptide-Based Vaccines for Cancer Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Peptide-Based Vaccines for Cancer Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Peptide-Based Vaccines for Cancer Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Peptide-Based Vaccines for Cancer Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Peptide-Based Vaccines for Cancer Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Peptide-Based Vaccines for Cancer Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Peptide-Based Vaccines for Cancer Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Peptide-Based Vaccines for Cancer Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Peptide-Based Vaccines for Cancer Sales (K Units) by Type (2020-2025)
Table 51. Global Peptide-Based Vaccines for Cancer Sales (K Units) by Type (2026-2031)
Table 52. Global Peptide-Based Vaccines for Cancer Sales Market Share by Type (2020-2025)
Table 53. Global Peptide-Based Vaccines for Cancer Sales Market Share by Type (2026-2031)
Table 54. Global Peptide-Based Vaccines for Cancer Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Peptide-Based Vaccines for Cancer Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Peptide-Based Vaccines for Cancer Revenue Market Share by Type (2020-2025)
Table 57. Global Peptide-Based Vaccines for Cancer Revenue Market Share by Type (2026-2031)
Table 58. Global Peptide-Based Vaccines for Cancer Price (US$/Unit) by Type (2020-2025)
Table 59. Global Peptide-Based Vaccines for Cancer Price (US$/Unit) by Type (2026-2031)
Table 60. Global Peptide-Based Vaccines for Cancer Sales (K Units) by Application (2020-2025)
Table 61. Global Peptide-Based Vaccines for Cancer Sales (K Units) by Application (2026-2031)
Table 62. Global Peptide-Based Vaccines for Cancer Sales Market Share by Application (2020-2025)
Table 63. Global Peptide-Based Vaccines for Cancer Sales Market Share by Application (2026-2031)
Table 64. Global Peptide-Based Vaccines for Cancer Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Peptide-Based Vaccines for Cancer Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Peptide-Based Vaccines for Cancer Revenue Market Share by Application (2020-2025)
Table 67. Global Peptide-Based Vaccines for Cancer Revenue Market Share by Application (2026-2031)
Table 68. Global Peptide-Based Vaccines for Cancer Price (US$/Unit) by Application (2020-2025)
Table 69. Global Peptide-Based Vaccines for Cancer Price (US$/Unit) by Application (2026-2031)
Table 70. AmbioPharm Company Information
Table 71. AmbioPharm Description and Business Overview
Table 72. AmbioPharm Peptide-Based Vaccines for Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. AmbioPharm Peptide-Based Vaccines for Cancer Product
Table 74. AmbioPharm Recent Developments/Updates
Table 75. Almac Company Information
Table 76. Almac Description and Business Overview
Table 77. Almac Peptide-Based Vaccines for Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Almac Peptide-Based Vaccines for Cancer Product
Table 79. Almac Recent Developments/Updates
Table 80. ACT Company Information
Table 81. ACT Description and Business Overview
Table 82. ACT Peptide-Based Vaccines for Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. ACT Peptide-Based Vaccines for Cancer Product
Table 84. ACT Recent Developments/Updates
Table 85. Ultimovacs Company Information
Table 86. Ultimovacs Description and Business Overview
Table 87. Ultimovacs Peptide-Based Vaccines for Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Ultimovacs Peptide-Based Vaccines for Cancer Product
Table 89. Ultimovacs Recent Developments/Updates
Table 90. Marker Therapeutics, Inc. Company Information
Table 91. Marker Therapeutics, Inc. Description and Business Overview
Table 92. Marker Therapeutics, Inc. Peptide-Based Vaccines for Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Marker Therapeutics, Inc. Peptide-Based Vaccines for Cancer Product
Table 94. Marker Therapeutics, Inc. Recent Developments/Updates
Table 95. Immatics Company Information
Table 96. Immatics Description and Business Overview
Table 97. Immatics Peptide-Based Vaccines for Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Immatics Peptide-Based Vaccines for Cancer Product
Table 99. Immatics Recent Developments/Updates
Table 100. OncoPep Company Information
Table 101. OncoPep Description and Business Overview
Table 102. OncoPep Peptide-Based Vaccines for Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. OncoPep Peptide-Based Vaccines for Cancer Product
Table 104. OncoPep Recent Developments/Updates
Table 105. Anergis Company Information
Table 106. Anergis Description and Business Overview
Table 107. Anergis Peptide-Based Vaccines for Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Anergis Peptide-Based Vaccines for Cancer Product
Table 109. Anergis Recent Developments/Updates
Table 110. Sellas Life Sciences Company Information
Table 111. Sellas Life Sciences Description and Business Overview
Table 112. Sellas Life Sciences Peptide-Based Vaccines for Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Sellas Life Sciences Peptide-Based Vaccines for Cancer Product
Table 114. Sellas Life Sciences Recent Developments/Updates
Table 115. Immatics Company Information
Table 116. Immatics Description and Business Overview
Table 117. Immatics Peptide-Based Vaccines for Cancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Immatics Peptide-Based Vaccines for Cancer Product
Table 119. Immatics Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Peptide-Based Vaccines for Cancer Distributors List
Table 123. Peptide-Based Vaccines for Cancer Customers List
Table 124. Peptide-Based Vaccines for Cancer Market Trends
Table 125. Peptide-Based Vaccines for Cancer Market Drivers
Table 126. Peptide-Based Vaccines for Cancer Market Challenges
Table 127. Peptide-Based Vaccines for Cancer Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Peptide-Based Vaccines for Cancer
Figure 2. Global Peptide-Based Vaccines for Cancer Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peptide-Based Vaccines for Cancer Market Share by Type: 2024 & 2031
Figure 4. Synthetic Polypeptide Vaccines Product Picture
Figure 5. Recombinant Polypeptide Vaccine Product Picture
Figure 6. Other Product Picture
Figure 7. Global Peptide-Based Vaccines for Cancer Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Peptide-Based Vaccines for Cancer Market Share by Application: 2024 & 2031
Figure 9. Infectious Disease Prevention
Figure 10. Cancer Immunotherapy
Figure 11. Other
Figure 12. Global Peptide-Based Vaccines for Cancer Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Peptide-Based Vaccines for Cancer Market Size (2020-2031) & (US$ Million)
Figure 14. Global Peptide-Based Vaccines for Cancer Sales (2020-2031) & (K Units)
Figure 15. Global Peptide-Based Vaccines for Cancer Average Price (US$/Unit) & (2020-2031)
Figure 16. Peptide-Based Vaccines for Cancer Report Years Considered
Figure 17. Peptide-Based Vaccines for Cancer Sales Share by Manufacturers in 2024
Figure 18. Global Peptide-Based Vaccines for Cancer Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Peptide-Based Vaccines for Cancer Players: Market Share by Revenue in Peptide-Based Vaccines for Cancer in 2024
Figure 20. Peptide-Based Vaccines for Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Peptide-Based Vaccines for Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Peptide-Based Vaccines for Cancer Sales Market Share by Country (2020-2031)
Figure 23. North America Peptide-Based Vaccines for Cancer Revenue Market Share by Country (2020-2031)
Figure 24. United States Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Peptide-Based Vaccines for Cancer Sales Market Share by Country (2020-2031)
Figure 27. Europe Peptide-Based Vaccines for Cancer Revenue Market Share by Country (2020-2031)
Figure 28. Germany Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Peptide-Based Vaccines for Cancer Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Peptide-Based Vaccines for Cancer Revenue Market Share by Region (2020-2031)
Figure 35. China Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Peptide-Based Vaccines for Cancer Sales Market Share by Country (2020-2031)
Figure 43. Latin America Peptide-Based Vaccines for Cancer Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Colombia Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Peptide-Based Vaccines for Cancer Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Peptide-Based Vaccines for Cancer Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Peptide-Based Vaccines for Cancer Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Peptide-Based Vaccines for Cancer by Type (2020-2031)
Figure 54. Global Revenue Market Share of Peptide-Based Vaccines for Cancer by Type (2020-2031)
Figure 55. Global Peptide-Based Vaccines for Cancer Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Peptide-Based Vaccines for Cancer by Application (2020-2031)
Figure 57. Global Revenue Market Share of Peptide-Based Vaccines for Cancer by Application (2020-2031)
Figure 58. Global Peptide-Based Vaccines for Cancer Price (US$/Unit) by Application (2020-2031)
Figure 59. Peptide-Based Vaccines for Cancer Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
